Allakos Inc. (ALLK): Price and Financial Metrics
ALLK Price/Volume Stats
| Current price | $1.20 | 52-week high | $3.36 |
| Prev. close | $1.29 | 52-week low | $0.54 |
| Day low | $1.20 | Volume | 474,400 |
| Day high | $1.38 | Avg. volume | 797,450 |
| 50-day MA | $1.09 | Dividend yield | N/A |
| 200-day MA | $1.00 | Market Cap | 107.21M |
ALLK Stock Price Chart Interactive Chart >
Allakos Inc. (ALLK) Company Bio
Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. The company was founded in 2012 and is based in San Carlos, California.
ALLK Price Returns
| 1-mo | 32.32% |
| 3-mo | 121.40% |
| 6-mo | 0.00% |
| 1-year | -54.72% |
| 3-year | -85.96% |
| 5-year | -88.29% |
| YTD | -56.04% |
| 2023 | -67.58% |
| 2022 | -13.99% |
| 2021 | -30.07% |
| 2020 | 46.81% |
| 2019 | 82.44% |
Loading social stream, please wait...